• Entecavir: From BMS200475 to HBV Therapy

  2026-08-22

  The reference study presents Entecavir, also known as BMS200475, as a highly potent nucleoside analogue that targets the multifunctional HBV DNA polymerase. Its integration of biochemical, animal-model, resistance, and controlled clinical evidence established a rationale for durable viral suppression and informed subsequent chronic hepatitis B infection therapy.

• Oligomycin A Workflows for Mitochondrial Bioenergetics

  2026-08-21

  Oligomycin A provides a direct, controllable way to isolate ATP synthase-dependent respiration from broader mitochondrial dysfunction. This practical guide connects respiratory flux, ROS, apoptosis, cancer metabolism, and sodium-driven energy failure to help researchers design interpretable assays and troubleshoot common handling problems.

• JNJ-26854165 (Serdemetan) Workflow Guide

  2026-08-21

  Build more informative p53-pathway experiments with JNJ-26854165 (Serdemetan), an HDM2 antagonist that separates growth arrest from cell killing. This practical guide covers dose selection, orthogonal viability and apoptosis readouts, migration controls, and radiosensitization study design.

• ZCL278: Selective Cdc42 Inhibitor Workflows

  2026-08-20

  ZCL278 is a practical pharmacological probe for connecting Cdc42 activity with cell migration, neuronal morphology, and fibroblast signaling. This workflow-centered guide covers dose planning, orthogonal readouts, pathway validation, and troubleshooting across cancer, neurobiology, and fibrosis-oriented models.

• LPS Protection of Macrophages via System Xc− and ABCC1

  2026-08-20

  The reference study shows that lipopolysaccharide protects macrophages from antitumor drug–induced injury without producing a comparable protective effect in tumor cells. Its mechanistic contribution is the link between LPS exposure, system Xc−-supported glutathione synthesis, and ABCC1-associated drug handling, although the inhibitor data require careful interpretation because MK-571 has pharmacology beyond ABCC1.

• TUNEL Apoptosis Detection Kit for Glioma Studies

  2026-08-19

  Learn how the TUNEL Apoptosis Detection Kit converts DNA fragmentation into spatial evidence for glioma research. This article connects the TUNEL assay with network pharmacology, molecular docking, cultured-cell experiments, and tissue-level validation.

• Breast Cancer Dependence on MCL-1: Apoptotic Function

  2026-08-19

  This study demonstrates that established breast tumors depend on MCL-1 primarily because of its canonical anti-apoptotic activity. By combining conditional genetic deletion, selective pharmacological inhibition, and BAX/BAK epistasis experiments, the authors connect MCL-1 dependence to mitochondrial apoptosis while also identifying an important role in breast cancer stem cell activity.

• E-64d for Calpain and Cathepsin Research

  2026-08-18

  E-64d is a membrane-permeable, irreversible cysteine protease inhibitor for connecting intracellular protease activity with measurable changes in apoptosis, lysosomal injury, platelet activation, and neuronal stress. This workflow-focused guide explains how to prepare, dose, validate, and troubleshoot E-64d experiments while avoiding overinterpretation of broad calpain and cathepsin inhibition.

• Losmapimod Workflows for p38 MAPK Research

  2026-08-18

  Losmapimod enables controlled investigation of p38α/β signaling across inflammatory, endothelial, vascular, and COPD research models. This workflow-focused guide links formulation, phospho-kinase readouts, nitric oxide assays, and dephosphorylation experiments to practical troubleshooting decisions.

• Hesperadin: A Functional Map of Mitotic Failure

  2026-08-17

  Hesperadin is an Aurora B kinase inhibitor used to connect kinase inhibition with chromosome segregation, cytokinesis, and checkpoint behavior. This article presents an assay framework that distinguishes Aurora B-dependent mitotic failure from mitotic checkpoint complex disassembly.

• Phosphatase Inhibitor Cocktail 1: Practical Use

  2026-08-16

  Phosphatase Inhibitor Cocktail 1 (100X in DMSO) helps limit endogenous phosphatase activity during preparation of animal tissue and cultured-cell samples, supporting preservation of protein phosphorylation for downstream assays. It is intended for research workflows, not diagnostic or medical use, and requires assay-specific validation because the dossier does not provide universal working conditions or direct matched paper evidence.

• H-89: cAMP-Dependent Protein Kinase Inhibitor

  2026-08-15

  H-89 is a cAMP-dependent protein kinase inhibitor used to examine protein kinase A inhibition and cAMP signaling pathway modulation. Its product-reported biochemical IC50 is 48 nM, but cellular interpretation requires solvent, exposure, viability, and off-target controls.

• Neurotensin: From GPCR Trafficking to Translation

  2026-08-15

  Neurotensin offers translational researchers a controllable way to connect NTR1 activation with receptor recycling and miR-133α modulation. This article presents a mechanistic validation strategy, assay-quality framework, and cautious path from gastrointestinal cell biology toward translational relevance.

• KX2-391 Dihydrochloride: Assay Strategy

  2026-08-14

  KX2-391 dihydrochloride, also known as Tirbanibulin dihydrochloride, is a versatile probe for connecting Src signaling, tubulin dynamics, HPV biology, and HBV transcription. This evidence-led guide explains how to select assays, interpret pathway effects, and avoid overextending findings across oncology, virology, and neurotoxin research.

• Primidone (Mysoline): From Drug to Translational Platform

  2026-08-14

  Primidone, also known as Mysoline, is emerging as more than a conventional antiepileptic drug. Its dual activity across TRPM3 and RIPK1 creates a translational bridge between ion-channel biology, neuroinflammation, neurodevelopmental disease, and pain research. This article examines the mechanistic rationale, evidence boundaries, protocol design, and strategic opportunities for advancing Primidone from repurposed compound to research platform.

450 records 7/30 page Previous Next First page 上5页 678910 下5页 Last page